11

1
1

Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer

Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer
Condition:   Colorectal Cancer
Interventions:   Drug: fluorouracil;   Drug: gemcitabine hydrochloride;   Drug: leucovorin calcium;   Procedure: chemotherapy
Sponsor:   Stony Brook University
Active, not recruiting - verified April 2002

Outpatient Evaluation of Patients With Known or Suspected Heart Disease
Condition:   Heart Disease
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified December 2001

Evaluation of the Association of Polymorphisms in the Innate Immune System With the Risk for Cryptococcus Neoformans Infection in Patients Not Infected With HIV and Complications Associated With Cryptococcus Neoformans Infection
Condition:   Cryptococcosis
Intervention:  
Sponsor:   National Cancer Institute (NCI)
Active, not recruiting - verified July 2005

Cyclophosphamide and Filgrastim in Treating Patients With Stage IV, Relapsed, or Refractory Low-Grade Follicular Non-Hodgkin's Lymphoma
Condition:   Lymphoma
Interventions:   Drug: cyclophosphamide;   Drug: filgrastim;   Procedure: chemotherapy;   Procedure: colony-stimulating factor therapy
Sponsors:   Cancer and Leukemia Group B;   National Cancer Institute (NCI)
Active, not recruiting - verified May 2005

A Study of Zidovudine in HIV-Infected Patients With Liver Disease
Conditions:   HIV Infections;   Liver Diseases
Intervention:   Drug: Zidovudine
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Completed - verified August 1991

Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer
Condition:   Colorectal Cancer
Interventions:   Drug: fluorouracil;   Drug: gemcitabine hydrochloride;   Drug: leucovorin calcium;   Procedure: chemotherapy
Sponsor:   Stony Brook University
Active, not recruiting - verified April 2002

Outpatient Evaluation of Patients With Known or Suspected Heart Disease
Condition:   Heart Disease
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified December 2001

Evaluation of the Association of Polymorphisms in the Innate Immune System With the Risk for Cryptococcus Neoformans Infection in Patients Not Infected With HIV and Complications Associated With Cryptococcus Neoformans Infection
Condition:   Cryptococcosis
Intervention:  
Sponsor:   National Cancer Institute (NCI)
Active, not recruiting - verified July 2005

Cyclophosphamide and Filgrastim in Treating Patients With Stage IV, Relapsed, or Refractory Low-Grade Follicular Non-Hodgkin's Lymphoma
Condition:   Lymphoma
Interventions:   Drug: cyclophosphamide;   Drug: filgrastim;   Procedure: chemotherapy;   Procedure: colony-stimulating factor therapy
Sponsors:   Cancer and Leukemia Group B;   National Cancer Institute (NCI)
Active, not recruiting - verified May 2005

A Study of Zidovudine in HIV-Infected Patients With Liver Disease
Conditions:   HIV Infections;   Liver Diseases
Intervention:   Drug: Zidovudine
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Completed - verified August 1991